Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States

Several types of antibodies (Abs) are currently used in non-small cell lung cancer (NSCLC). Anti-angiogenic and immune checkpoint inhibitor (ICI) Abs are the most frequent treatments used alone or with chemotherapy in metastatic NSCLC, for the front line and beyond. Considering the many therapeutic...

全面介紹

書目詳細資料

Principais autores:	Marion Ferreira, Thomas Secher, Nathalie Heuze-Vourc’H, Karen L Reckamp
格式:	Artigo
語言:	Inglês
出版:	MDPI AG 2021-06-01
叢編:	Pharmaceutics
主題:	lung cancer immune checkpoint inhibitors anti-angiogenic antibodies cancer treatment
在線閱讀:	https://www.mdpi.com/1999-4923/13/6/912
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!